Through the strategic acquisition of a new factory in Spain, Septodont, a global leader in dental pain management, strengthens its manufacturing presence in the Iberian Peninsula. This expansion will increase the production capacity of dental needles by 50% while meeting future regulatory requirements. Since its founding in 1932 in Saint-Maur-des-Fossés, Septodont has been committed to improving patients’ lives with innovative, safe, and effective solutions.
The French company Septodont, a global specialist in dental pain management, is significantly increasing its production capacity with the opening of a new factory in Spain. This initiative stems from a recent strategic acquisition that also allows them to strengthen their manufacturing presence in Spain and Portugal. This expansion aims to meet future regulatory requirements and improve the production of dental needles by 50%.
A strategic expansion in Spain
Septodont recently acquired a Spanish company; this strategic move aims to expand its footprint in the Spanish and Portuguese markets. This purchase gives them access to modern infrastructure to produce a diverse range of dental products, including dental anesthetics and other medical devices.
Strengthening production capacity
With the inauguration of this new factory, Septodont plans to increase its production capacity of dental needles by 50%. This substantial growth is made possible by state-of-the-art facilities that meet the industry’s strictest standards. The opening of the factory in 2021 will also enable compliance with future regulatory requirements.
A key factory for innovation
Septodont’s new Spanish factory is designed to be a hub of innovation and research. In collaboration with other entities such as Crown Ceram, Septodont focuses on developing high-performance and effective solutions. A recent example is the webinar organized to promote new products such as Biodentine™ XP.
Commitment to quality and safety
Septodont has always been committed to providing innovative, safe, and effective solutions to improve patients’ lives. This new factory in Spain will further enhance this commitment, producing products of the highest quality that comply with existing regulations.
Implications of the expansion
This expansion is not only beneficial for Septodont, but it also marks a significant shift in the European dental sector. By expanding its production capacity, Septodont is not only responding to growing demand but also driving research and development of new dental solutions.
Conclusion of the expansion
With this new factory, Septodont continues to position itself as a global leader in dental pain management. This expansion in Spain is a significant step that not only amplifies their production capacity but also enables them to meet the future needs of the dental industry. It is a concrete example of their commitment to improving global dental health through innovation and quality.
